Intel and Microsoft's Remote Patient Monitoring Announcements

Are They Dual or Dueling Efforts?

Publication Date	November 2008
Publisher	IDC
Product Type	Report
Pages	7
ISBN Number	not applicable
Product Code	IDC06205

Buy this product or for assistance call +44 20 7060 7474

PDF £900.00$1497 | €1007

FAX Order above formats by FAX

Summary

This Health Industry Insights Perspective compares and contrasts two separate announcements by Intel and Microsoft, both made on November 10, 2008, of remote patient monitoring (RPM) pilot projects each firm is conducting with leading healthcare organizations:

Intel is conducting field trials of its new Intel Health Guide (IHG), an Food and Drug Administration (FDA)-cleared medical device that connects patients with chronic conditions to their providers, at four separate healthcare organizations representing four different care management delivery models.
Microsoft and the Cleveland Clinic are conducting a similar remote patient monitoring pilot study that will involve a combination of commercially available home health monitoring devices, Microsoft HealthVault and Cleveland Clinic's MyChart personal health record system.

Content

In This Perspective
- Situation Overview
  - Intel Launches Intel Health Guide, a FDA-Cleared RPM Medical Device
  - Microsoft Pilots HealthVault and Its Medical Device Connectivity at Cleveland Clinic
- Essential Guidance
  - Who Will Provide the Back-End Data Monitoring?
  - How Interoperable Is the Device and How Easily Can Other Devices Be Connected to the Future?
  - Who Pays for the Device and Infrastructure?
  - How Will Consumers Respond to the Technology?
- Future Outlook
Learn More
- Related Research